Loading organizations...
Smith+Nephew is a global medical technology firm specializing in devices and solutions for the repair, regeneration, and replacement of soft and hard tissue. The company develops and markets an extensive portfolio of products across Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, encompassing a range of surgical and therapeutic technologies designed to address complex clinical needs. Their focus is on advancing techniques and developing innovative products that support patient recovery and improve outcomes.
The company's origins trace back to 1856 when Thomas James Smith established a small chemist shop in Hull, England. From these humble beginnings, Smith's entrepreneurial spirit and dedication to healthcare led to the gradual expansion of the business, laying the groundwork for a multinational enterprise that would eventually become a prominent name in medical technology. His initial insight revolved around providing essential medical supplies and care products.
Smith+Nephew's offerings serve a broad customer base, including surgeons, hospitals, and healthcare systems seeking advanced solutions for musculoskeletal health and wound care. The company’s overarching vision is centered on restoring people’s lives by pioneering medical advancements that alleviate pain, accelerate recovery, and enable individuals to regain their mobility and independence. They remain committed to continuous innovation within their specialized fields.
Key people at Smith & Nephew.
Smith & Nephew has 4 tracked investments across 2 companies. The latest tracked deal is $20.0M Series B Extension in Miach Orthopaedics in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 2, 2024 | Miach Orthopaedics | $20.0M Series B Extension | — | Joyce Erony, Aperture Venture Partners, Endeavour Vision, Major League Soccer Players Association, Miach Orthopaedics, NFL Players Association, Sectoral Asset Management, SV Health Investors |
| Jan 25, 2023 | Miach Orthopaedics | $40.0M Debt / Series B | Endeavour Vision, Sectoral Asset Management | Joyce Erony, NFL Players Association, Silicon Valley Bank |
| Jan 14, 2019 | Trice Medical | $18.3M Series C Extension | John Kerschen, Municipal Employee Retirement System OF Michigan | BioStar Ventures, HealthQuest Capital, Safeguard Scientifics |
| Jun 6, 2017 | Trice Medical | $19.3M Series C | — | BioStar Ventures, HealthQuest Capital, Safeguard Scientifics |
Smith & Nephew is a global medical technology company specializing in advanced wound management, orthopaedics, and sports medicine products. It serves healthcare providers worldwide by developing innovative medical devices and solutions that address critical surgical and wound care needs, improving patient outcomes and healthcare efficiency. With a 2024 revenue of approximately $5.81 billion, the company demonstrates strong growth momentum driven by continuous product innovation and strategic acquisitions in the medical device sector[1][2].
Founded in 1856 by Thomas James Smith as a small dispensing chemist shop in Hull, England, Smith & Nephew evolved from producing cod liver oil to focusing on surgical dressings and bandages, especially during World War I when it supplied dressings for wounded soldiers. The company was incorporated in 1937 and expanded globally through acquisitions such as Richards Medical Company in 1999 and Centerpulse AG Orthopedics in 2001, solidifying its position in orthopaedics and wound care[1][5][7].
Smith & Nephew rides the global trend of increasing demand for advanced medical technologies driven by aging populations, rising chronic diseases, and healthcare system modernization. The timing is favorable due to growing investments in minimally invasive surgery and wound care innovations. Market forces such as regulatory support for medical devices and expanding healthcare infrastructure in emerging markets further bolster its growth. The company influences the broader ecosystem by setting standards in medical device innovation and supporting clinical education and research partnerships[1][4].
Looking ahead, Smith & Nephew is poised to capitalize on trends like digital health integration, personalized medicine, and regenerative technologies. Its continued focus on innovation, strategic acquisitions, and global market expansion will likely enhance its influence in medical technology. The company’s ability to adapt to evolving healthcare needs and regulatory environments will shape its trajectory, potentially making it a key player in next-generation surgical and wound care solutions.
Smith & Nephew’s long history of innovation and adaptation, from a small chemist shop to a global medical technology leader, underscores its resilience and commitment to improving patient care worldwide[1][5].
Key people at Smith & Nephew.
